BRENUS PHARMA Trademark
Serial Number: 79356895 • Registration: 7265441
BRENUS PHARMA is a trademark filed by
BRENUS PHARMA
on September 19, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Pina Campagna Carter, DeLuca, and Farrell, LLP
576 Broad Hollow Rd.
Melville
NY 11747
UNITED STATES
Trademark Details
Filing Date
September 19, 2022
Registration Date
January 9, 2024
Published for Opposition
October 24, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
May 8, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 12, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 24, 2023 ADCH
NOTIFICATION PROCESSED BY IB
Oct 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 29, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2023 RFCS
REFUSAL PROCESSED BY MPU
Aug 8, 2023 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 23, 2023 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 4, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jul 3, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 13, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 8, 2022 REPR
